MYC and lymphoma: Moreover, the deletion of miR-17-92 in established MYC-driven lymphoma cell lines decreased the capability to growth in tissue culture and immunodeficient hosts, in keeping with the concept that miR-17-92 levels influences proliferation of these cells [39].